The Effect of Deep Neuromuscular Block on the Perioperative Stress Response Reduction and Postoperative Recovery Enhancement in Robot-assisted Stomach Cancer Surgery

Yonsei University

Status: Completed

Conditions: Stomach Cancer

Treatments: Drug: Moderate neuromuscular block with 'rocunium®'; Drug: Deep neuromuscular block with 'rocunium®'

Study type: Interventional

Funder types: Other

Identifiers

NCT03937440

4-2019-0205

Details and patient eligibility

About

Stress reactions caused by surgical stimuli can cause sympathetic nervous system activation and increased stress hormones, such as catecholamines, inflammatory cytokines, and pituitary hormones, and insulin resistance. In addition, increased catecholamine levels may exacerbate postoperative outcomes, especially delayed wound recovery, increased cardiovascular and respiratory complications, and immunosuppression. In particular, it is important to reduce the stress response for cancer patients during surgery because they are already immunocompromised status and more vulnerable to perioperative stressful situation. However, there are insufficient results on the benefits of deep neuromuscular block in these patients, although some have reported a reduction of postoperative pain and fewer complications in the deep neuromuscular block compared with moderate neuromuscular block. Therefore, the investigators aim to investigate the difference in the stress response of patients who received conventional moderate neuromuscular block or deep neuromuscular block in robot-assisted gastric cancer surgery.

Enrollment: 46 patients

Sex: All

Ages: 20 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 1. ASA Ⅰ - Ⅱ patients between 20 and 65 years undergoing robot-assisted gastric cancer surgery

Exclusion criteria

• 1. Patients with neuromuscular disease
• 2. Hypertensive patients with β-blockers
• 3. Diabetic patients receiving insulin therapy
• 4. Patients with severe heart (EF <45%), kidney (GFR <60), liver dysfunction (ALT / AST> 100)
• 5. Patients with obesity (BMI ≥30)
• 6. Do not understand Korean language
• 7. For vulnerable subjects who are unable to obtain consent

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

46 participants in 2 patient groups

Deep neuromuscular block group

Experimental group

Treatment:

Drug: Deep neuromuscular block with 'rocunium®'

Moderate neuromuscular block group

Experimental group

Treatment:

Drug: Moderate neuromuscular block with 'rocunium®'